Newsletter
Get Healthcare AI Briefings
Monthly procurement notes on clinical AI categories, validation, compliance, and vendor changes.
AI imaging software for cancer screening and oncology workflows.
Lunit develops AI software for cancer screening and treatment-related workflows, including imaging analysis products for radiology and oncology teams.
Reliability of claims, output quality, and evidence fit.
Fit for clinical, revenue, or operations workflows.
HIPAA, PHI, BAA, and governance readiness signals.
Value relative to expected cost, onboarding, and effort.
Maturity, documentation, support, and market signals.
This review has not published a long-form introduction yet.
Not publicly listed; verify pricing, modules, and deployment terms with Lunit.
HIPAA
Not reviewed
BAA
Not reviewed
Confirm product-level regulatory status, intended use, BAA terms, image data processing, clinical oversight, performance monitoring, and integration responsibilities.
HealthAIdir used vendor public materials for this seed profile. No vendor paid for placement, and buyers should verify all compliance, pricing, and implementation claims directly with Lunit.
Featured or sponsor placement does not affect HealthAIdir scores, verdicts, comparisons, or editorial recommendations.
Evidence: Lunit official pages describe AI radiology software for cancer screening and imaging analysis workflows, with a public privacy-policy page for buyer diligence. Sources: https://www.lunit.io/ | https://www.lunit.io/en/ai-radiology-software/ | https://www.lunit.io/en/privacy-policy/